Cambridge Healthtech Institute’s 2nd Annual

Antibody-Based Cancer Therapies

Driving Breakthrough Therapies

5 November 2024


The pursuit of more effective and targeted cancer therapies is spurring the evolution of antibody-based treatments. At the Antibody-Based Cancer Therapies conference, we will explore the potential of emerging antibody formats that are driving the oncology field, including novel antibody scaffolds, multispecifics, complex bioconjugates, and antibody-based cell therapies. Attendees will gain insights into the broadening therapeutic landscape that includes protein degraders, immunocytokines, and nucleic acids, while witnessing the power of combination therapies that are pushing the boundaries of cancer treatment.

Coverage will include, but is not limited to:

  • Next Generation Antibody Formats
    • Single-domain antibodies and nanobodies
    • Alternative Scaffolds—shark VNARs, DARPins, affibodies
    • Bispecifics and multispecific antibodies
    • Biparatopic antibodies
    • Antibody-drug conjugates, peptide-drug conjugates, degrader-antibody conjugates
    • Masked antibodies/ conditionally activated antibodies/Antibody Prodrugs
  • Antibody-Based Cell Therapies
    • T cell engagers
    • CARs—CAR T, CAR M, CAR NK
    • TILs
  • Antibodies as Targeted Delivery
    • Antibody-radionuclide conjugates
    • Antibody-targeted nanoparticles
  • Beyond Antibodies
    • PROTACs and ATTECs
    • Immunocytokines
    • Nucleic Acids—mRNA, ASO, oligonucleotides
  • Combination Strategies
    • Antibody-based therapies with small molecule inhibitors, checkpoint inhibitors, oncolytic viruses, cytokines

The deadline for priority consideration is 29 March 2024.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com